European regulators cleared Moderna’s first-of-its-kind vaccine as US approval remains uncertain. On Friday, Moderna’s ...

Stanford researchers develop breakthrough nasal spray vaccine that could potentially protect against a variety of infections, ...

Dr. Vinay Prasad, vaccine chief at the the U.S. Food and Drug Administration (FDA), said in an internal memo in November that ...

Feb 26 (Reuters) - ⁠The ⁠U.S. CDC's ⁠vaccine advisory committee will ​discuss and may ‌vote on recommendations ‌for issues ...

COVID-19 vaccinations were shown to reduce virus-related hospitalizations and severe disease-associated outcomes in immunocompetent adults. The findings from a recently published JAMA Network Open ...

Covid vaccines are once again on the agenda for the Centers for Disease Control and Prevention’s vaccine advisory panel.

If the recommendation is accepted by the European Commission, Moderna's mCombriax vaccine will be available for adults 50 and older throughout the European Union.

The committee’s reputation has taken a nosedive, however, following HHS Secretary Robert F. Kennedy Jr.’s decision to purge ...

Earlier this month, major U.S. medical groups asked a federal judge to block the administration from implementing new guidance that cuts the number of vaccines routinely recommended for children and ...

The Centers for Disease Control and Prevention’s influential vaccine advisory panel will consider issuing recommendations ...

A rare but serious clotting disorder linked to certain COVID-19 vaccines and natural adenovirus infections has puzzled scientists for years.